SONM vs WTO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits extreme financial distress, highlighted by a Piotroski F-Score of 0/9, indicating a total lack of fundamental health. With a Quick Ratio of 0.03 and a negative Price-to-Book ratio of -4.35, the firm is facing a severe liquidity crisis and possesses negative shareholders' equity. Catastrophic Q/Q revenue growth of -394.48% and a 5-year price decline of 99.7% suggest a business in terminal decline. The lack of an Altman Z-Score calculation is likely due to the absence of positive working capital or equity, further signaling insolvency risk.
UTime Limited exhibits critical financial distress, anchored by a weak Piotroski F-Score of 3/9 and a catastrophic 1-year price decline of 99.7%. The company is suffering from severe profitability collapse, evidenced by a profit margin of -251.46% and an ROE of -253.66%. While valuation multiples like P/B (0.07) and P/S (0.02) appear low, they are classic value traps given the -28.10% revenue growth and high leverage (Debt/Equity 1.83). The technical trend is completely bearish, indicating a total loss of investor confidence.
Compare Another Pair
Related Comparisons
SONM vs WTO: Head-to-Head Comparison
This page compares DNA X, Inc. (SONM) and UTime Limited (WTO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.